AI
Allostery Investments Portfolio holdings
AUM
$7.85M
This Quarter Return
-7.49%
1 Year Return
–
3 Year Return
–
5 Year Return
–
10 Year Return
–
AUM
$50.9M
AUM Growth
–
Cap. Flow
+$50.9M
Cap. Flow
% of AUM
100%
Top 10 Holdings %
Top 10 Hldgs %
74%
Holding
39
New
30
Increased
–
Reduced
–
Closed
–
Top Buys
| 1 |
CNTA
Centessa Pharmaceuticals
CNTA
|
$4.77M |
| 2 |
Evolus
EOLS
|
$4.76M |
| 3 |
Apogee Therapeutics
APGE
|
$4.53M |
| 4 |
ABVX
Abivax
ABVX
|
$4.33M |
| 5 |
KalVista Pharmaceuticals
KALV
|
$4.06M |
Top Sells
No sells this quarter
Sector Composition
| 1 | Healthcare | 100% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
CNTA
1
Centessa Pharmaceuticals
CNTA
$2.29B
| $4.77M | 4.98% |
+284,517
| New | +$4.77M |
|
|
2
Evolus
EOLS
$482M
| $4.76M | 4.97% |
+431,117
| New | +$4.76M |
|
|
3
Apogee Therapeutics
APGE
$2.23B
| $4.53M | 4.73% |
+100,000
| New | +$4.53M |
|
|
ABVX
4
Abivax
ABVX
$6.09B
| $4.33M | 4.52% |
+591,253
| New | +$4.33M |
|
|
5
KalVista Pharmaceuticals
KALV
$710M
| $4.06M | 4.24% |
+479,100
| New | +$4.06M |
|
6
Zura Bio
ZURA
$131M
| $3.79M | 3.96% |
+1,515,126
| New | +$3.79M |
|
7
Alkermes
ALKS
$4.85B
| $3.45M | 3.61% |
+120,000
| New | +$3.45M |
|
8
Cytokinetics
CYTK
$5.68B
| $3.06M | 3.19% |
+65,000
| New | +$3.06M |
|
9
Arcellx
ACLX
$3.88B
| $2.68M | 2.8% |
+35,000
| New | +$2.68M |
|
10
Ionis Pharmaceuticals
IONS
$8.97B
| $2.27M | 2.37% |
+65,000
| New | +$2.27M |
|
|
JBIO
11
Jade Biosciences, Inc. Common Stock
JBIO
$260M
| $2.25M | 2.35% |
+850,684
| New | +$2.25M |
|
12
Xenon Pharmaceuticals
XENE
$2.98B
| $1.18M | 1.23% |
+30,000
| New | +$1.18M |
|
13
Context Therapeutics
CNTX
$74.5M
| $998K | 1.04% |
+950,166
| New | +$998K |
|
14
Merus
MRUS
$4.99B
| $914K | 0.95% |
+21,735
| New | +$914K |
|
15
MindMed
MNMD
$680M
| $905K | 0.95% |
+130,000
| New | +$905K |
|
16
Rallybio
RLYB
$21.6M
| $771K | 0.81% |
+803,398
| New | +$771K |
|
17
Tarsus Pharmaceuticals
TARS
$2.48B
| $753K | 0.79% |
+13,600
| New | +$753K |
|
18
Insmed
INSM
$30.2B
| $690K | 0.72% |
+10,000
| New | +$690K |
|
19
Gossamer Bio
GOSS
$578M
| $555K | 0.58% |
+613,028
| New | +$555K |
|
20
Dianthus Therapeutics
DNTH
$775M
| $545K | 0.57% |
+25,000
| New | +$545K |
|
21
Avalo Therapeutics
AVTX
$116M
| $545K | 0.57% |
+73,314
| New | +$545K |
|
22
Crinetics Pharmaceuticals
CRNX
$3.01B
| $496K | 0.52% |
+9,700
| New | +$496K |
|
23
Jasper Therapeutics
JSPR
$44.7M
| $470K | 0.49% |
+22,000
| New | +$470K |
|
24
BiomX
PHGE
$14.4M
| $470K | 0.49% |
+643,833
| New | +$470K |
|
|
CLYM
25
Climb Bio, Inc. Common Stock
CLYM
$146M
| $441K | 0.46% |
+244,988
| New | +$441K |
|